ASSOCIATION BETWEEN INFLAMMATORY MARKERS AND NEGATIVE SYMPTOMS IN INDIVIDUALS WITH PERSISTENT SYMPTOMS OF SCHIZOPHRENIA TREATED WITH CLOZAPINE

被引：0
|
作者：
Goldsmith, David
Kopelovich, Sarah [2 ]
Novacek, Derek [1 ]
Widener, Jonathon [1 ]
Wommack, Evanthia [1 ]
Felger, Jennifer [1 ]
Miller, Andrew
Cotes, Robert [1 ]
机构：
[1] Emory Univ, Atlanta, GA 30322 USA
[2] Univ Washington, Seattle, WA 98195 USA
来源：
SCHIZOPHRENIA BULLETIN | 2017年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
SU63
引用
收藏
页码：S184 / S184
页数：1
相关论文
共 50 条
  • [1] Association Between Inflammatory Markers and Negative Symptoms in Individuals With Persistent Symptoms of Schizophrenia Treated With Clozapine
    Goldsmith, David
    Kopelovich, Sarah
    Novacek, Derek
    Widener, Jonathon
    Wommack, Evanthia
    Felger, Jennifer
    Miller, Andrew
    Cotes, Robert
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S390 - S391
  • [2] Adjunctive Minocycline in Clozapine Treated Schizophrenia Patients with Persistent Symptoms
    Kelly, Deanna
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S4 - S5
  • [3] Adjunct minocycline to clozapine treated patients with persistent schizophrenia symptoms
    Kelly, Deanna L.
    Vyas, Gopal
    Richardson, Charles M.
    Koola, Maju
    McMahon, Robert P.
    Buchanan, Robert W.
    SCHIZOPHRENIA RESEARCH, 2011, 133 (1-3) : 257 - 258
  • [4] Adjunctive Minocycline in Clozapine-Treated Schizophrenia Patients With Persistent Symptoms
    Kelly, Deanna L.
    Sullivan, Kelli M.
    McEvoy, Joseph P.
    McMahon, Robert P.
    Wehring, Heidi J.
    Gold, James M.
    Liu, Fang
    Warfel, Dale
    Vyas, Gopal
    Richardson, Charles M.
    Fischer, Bernard A.
    Keller, William R.
    Koola, Maju Mathew
    Feldman, Stephanie M.
    Russ, Jessica C.
    Keefe, Richard S. E.
    Osing, Jennifer
    Hubzin, Leeka
    August, Sharon
    Walker, Trina M.
    Buchanan, Robert W.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2015, 35 (04) : 374 - 381
  • [5] Adjunctive minocycline in clozapine and amisulpride treated schizophrenia patients with persistent symptoms
    Tzavellas, E.
    Karaiskos, D.
    Konstantinou, J.
    Oikonomou, E.
    Soldatos, R.
    Paparrigopoulos, T.
    EUROPEAN PSYCHIATRY, 2017, 41 : S842 - S842
  • [6] Synthetic Cannabinoids and Its Association With Persistent Negative Symptoms of Schizophrenia
    Satodiya, Ritvij
    Palekar, Nikhil
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (09)
  • [7] Persistent negative symptoms in schizophrenia: An overview
    Buchanan, Robert W.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (04) : 1013 - 1022
  • [8] Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis
    Goldsmith, David R.
    Haroon, Ebrahim
    Miller, Andrew H.
    Addington, Jean
    Bearden, Carrie
    Cadenhead, Kristin
    Cannon, Tyrone
    Cornblatt, Barbara
    Mathalon, Daniel
    McGlashan, Thomas
    Seidman, Larry
    Tsuang, Ming
    Woods, Scott W.
    Walker, Elaine F.
    Perkins, Diana O.
    BRAIN BEHAVIOR AND IMMUNITY, 2019, 76 : 268 - 274
  • [9] EEG Markers of Negative Symptoms in Schizophrenia
    Giordano, Giulia Maria
    INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY, 2021, 168 : S23 - S23
  • [10] Relations between neuropsychological vulnerability markers and negative symptoms in schizophrenia
    Suslow, T
    Junghanns, K
    Weitzsch, C
    Arolt, V
    PSYCHOPATHOLOGY, 1998, 31 (04) : 178 - 187
12345